141 related articles for article (PubMed ID: 10471407)
1. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
Ménoret A; Peng P; Srivastava PK
Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
[TBL] [Abstract][Full Text] [Related]
2. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
[TBL] [Abstract][Full Text] [Related]
3. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
[TBL] [Abstract][Full Text] [Related]
4. CD91: a receptor for heat shock protein gp96.
Binder RJ; Han DK; Srivastava PK
Nat Immunol; 2000 Aug; 1(2):151-5. PubMed ID: 11248808
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the immunomodulatory role of the heat shock protein gp96.
Robert J; Cohen N; Maniero GD; Goyos A; Morales H; Gantress J
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):263-75. PubMed ID: 12887107
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation?
Srivastava PK; Heike M
Semin Immunol; 1991 Jan; 3(1):57-64. PubMed ID: 1893123
[TBL] [Abstract][Full Text] [Related]
7. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
[TBL] [Abstract][Full Text] [Related]
8. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
Li Z; Srivastava PK
EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
[TBL] [Abstract][Full Text] [Related]
9. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
10. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
11. Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins.
Binder RJ; Kelly JB; Vatner RE; Srivastava PK
J Immunol; 2007 Dec; 179(11):7254-61. PubMed ID: 18025167
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with dendritic cells and tumor major histocompatibility complex class I-derived peptides requires a high density of antigen on tumor cells.
Rawson P; Hermans IF; Huck SP; Roberts JM; Pircher H; Ronchese F
Cancer Res; 2000 Aug; 60(16):4493-8. PubMed ID: 10969797
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.
Blachere NE; Li Z; Chandawarkar RY; Suto R; Jaikaria NS; Basu S; Udono H; Srivastava PK
J Exp Med; 1997 Oct; 186(8):1315-22. PubMed ID: 9334371
[TBL] [Abstract][Full Text] [Related]
14. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.
Suriano R; Ghosh SK; Ashok BT; Mittelman A; Chen Y; Banerjee A; Tiwari RK
Cancer Res; 2005 Jul; 65(14):6466-75. PubMed ID: 16024652
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
Udono H; Srivastava PK
J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
[TBL] [Abstract][Full Text] [Related]
16. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection.
Yamazaki K; Nguyen T; Podack ER
J Immunol; 1999 Nov; 163(10):5178-82. PubMed ID: 10553037
[TBL] [Abstract][Full Text] [Related]
18. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved.
Robert J; Ménoret A; Cohen N
J Immunol; 1999 Oct; 163(8):4133-9. PubMed ID: 10510348
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein gp96 and cancer immunotherapy.
Peibin Y; Shude Y; Changzhi H
Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96.
Goyos A; Cohen N; Gantress J; Robert J
Eur J Immunol; 2004 Sep; 34(9):2449-58. PubMed ID: 15307177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
